SCHEMBL10201666

SCHEMBL10201666

CCC/C=C\CCCCCCC(=O)O

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.84
▸ PPARD Q03181 5/20 0.84
▸ PPARA Q07869 5/20 0.84
▸ F7 P08709 5/20 0.84
▸ F3 P13726 5/20 0.84
▸ TERT O14746 3/20 0.84
▸ PTPN1 P18031 3/20 0.84
▸ HSD17B10 Q99714 3/20 0.84
▸ FABP4 P15090 3/20 0.84
▸ TOP1 P11387 3/20 0.84
▸ MAPT P10636 2/20 0.84
▸ BLM P54132 2/20 0.84
▸ LMNA P02545 2/20 0.84
▸ ALOX15 P16050 2/20 0.84
▸ DUSP3 P51452 2/20 0.84
▸ CYP19A1 P11511 2/20 0.84
▸ PTGS1 P23219 2/20 0.84
▸ NR4A2 P43354 2/20 0.84
▸ SIRT6 Q8N6T7 2/20 0.84
▸ PTPN7 P35236 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855222 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL2573063 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL2574228 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL2858103 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL552081 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL2575442 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL17048016 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL4303654 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL808536 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL2574226 1.00 PPARG (0.84) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109890832-A Half biology of fatty alcohol and fatty aldehyde is synthetically produced 普罗维维股份有限公司 2019-06-14 — — CN claimed
EP-3464311-A2 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES Provivi, Inc. (US) 2019-04-10 — — EP claimed
WO-2017214133-A2 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES PROVIVI, INC. (US) 2017-12-14 — — WO claimed
CN-115052856-B 3-Alkoxybenzamide derivative and pest control agent 组合化学工业株式会社 2024-10-08 — — CN disclosed
US-20220136018-A1 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES HORIZON TECHNOLOGY FINANCE CORPORATION 2022-05-05 — — US disclosed
US-11214818-B2 Semi-biosynthetic production of fatty alcohols and fatty aldehydes PROVIVI, INC. (US) 2022-01-04 — — US disclosed
US-20190136272-A1 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES HORIZON TECHNOLOGY FINANCE CORPORATION 2019-05-09 — — US disclosed
EP-3464311-A2 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES Provivi, Inc. (US) 2019-04-10 — — EP disclosed
WO-2017214133-A2 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES PROVIVI, INC. (US) 2017-12-14 — — WO disclosed
US-20140023751-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION Chemo S.A. France (FR) 2014-01-23 — — US disclosed
US-20140023751-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION Chemo S.A. France (FR) 2014-01-23 — — US disclosed
US-8545896-B2 Compositions, kits and methods for nutrition supplementation Chemo S. A. France (FR) 2013-10-01 — — US disclosed
US-8545896-B2 Compositions, kits and methods for nutrition supplementation Chemo S. A. France (FR) 2013-10-01 — — US disclosed
WO-2013049519-A2 COMPOSITIONS, KITS AND METHODS FOR NUTRITIONAL SUPPLEMENTATION WITH TWELVE CARBON CHAIN FATTY ACIDS AND TWELVE CARBON CHAIN ACYLGLYCEROLS Chemo S.A. France (FR) 2013-04-04 — — WO disclosed
US-20130084344-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION Chemo S.A. France (FR) 2013-04-04 — — US disclosed
US-20130084272-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITIONAL SUPPLEMENTATION WITH TWELVE CARBON CHAIN FATTY ACIDS AND TWELVE CARBON CHAIN ACYLGLYCEROLS Chemo S.A. France (FR) 2013-04-04 — — US disclosed
US-20130084344-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION Chemo S.A. France (FR) 2013-04-04 — — US disclosed
US-20130084272-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITIONAL SUPPLEMENTATION WITH TWELVE CARBON CHAIN FATTY ACIDS AND TWELVE CARBON CHAIN ACYLGLYCEROLS Chemo S.A. France (FR) 2013-04-04 — — US disclosed
US-8168611-B1 Compositions, kits and methods for nutrition supplementation Chemo S.A. France (FR) 2012-05-01 — — US disclosed
US-8168611-B1 Compositions, kits and methods for nutrition supplementation Chemo S.A. France (FR) 2012-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11214818-B2 Semi-biosynthetic production of fatty alcohols and fatty aldehydes FASN, FAR1, COASY PPARG 540/4885PPARD 686/4885PPARA 508/4885
US-20130084344-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION FADS1, FADS2, VDR PPARG 64/4885PPARD 277/4885PPARA 168/4885
US-20130084272-A1 COMPOSITIONS, KITS AND METHODS FOR NUTRITIONAL SUPPLEMENTATION WITH TWELVE CARBON CHAIN FATTY ACIDS AND TWELVE CARBON CHAIN ACYLGLYCEROLS ACSL5, FADS1, ACSL6 PPARG 83/4885PPARD 372/4885PPARA 119/4885
US-20220136018-A1 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES FASN, FAR1, COASY PPARG 540/4885PPARD 686/4885PPARA 508/4885
US-20190136272-A1 SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES FASN, FAR1, COASY PPARG 540/4885PPARD 686/4885PPARA 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback